Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Interdependency of selected metabolic variables in an animal model of metabolic syndrome

  • Authors:
    • Zoheir Mellouk
    • Abdullah Sener
    • Dalila Ait Yahia
    • Willy J. Malaisse
  • View Affiliations / Copyright

    Affiliations: Department of Biology, Es‑Sénia University, Oran, Algeria, Laboratory of Experimental Hormonology, Université Libre de Bruxelles, Brussels, Belgium
  • Pages: 1275-1278
    |
    Published online on: August 6, 2014
       https://doi.org/10.3892/etm.2014.1886
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In the present study, the correlation between the percentage of glycated hemoglobin, taken as representative of changes in glucose homeostasis, and selected variables was investigated. Rats were treated for 8 weeks with diets containing 64% starch and 5% sunflower oil or containing 64% D‑fructose mixed with: 5% sunflower oil; 3.4% sunflower oil and 1.6% salmon oil; or 3.4% sunflower oil and 1.6% safflower oil. Positive correlations were found between glycated hemoglobin and plasma albumin, urea, creatinine, phospholipids, triglycerides and total cholesterol, liver cholesterol, triglyceride and phospholipid content, and the plasma, liver, heart, kidney, soleus muscle and visceral adipose tissue content of thiobarbituric acid reactive substances, carbonyl derivatives and hydroperoxides. Inversely, negative correlations were observed between glycated hemoglobin and plasma calcium, iron and HDL‑cholesterol concentrations, liver, heart, kidney, soleus muscle and visceral adipose tissue superoxide dismutase and catalase activity; as well as plasma, liver, heart, kidney, soleus muscle and visceral adipose tissue nitric oxide content. Only the liver glucokinase activity and liver, heart, kidney, soleus muscle and visceral adipose tissue glutathione reductase activity failed to display a significant correlation with glycated hemoglobin. These findings confirm the hypothesis that there is a close association between glucose homeostasis and other variables when considering the effects of long‑chain polyunsaturated ω3 and ω6 fatty acids in rats with fructose‑induced metabolic syndrome.

Introduction

As previously reviewed (1), the induction of metabolic syndrome in rats by a fructose-rich diet has been, over recent years, the subject of several extensive investigations (2–10). The present study is founded on an extensive investigation of the post-mortem findings collected from rats exposed for 8 weeks to diets containing 64% starch and 5% sunflower oil (Ssun rats) or containing 64% D-fructose mixed with 5% sunflower oil (Fsun rats), 3.4% sunflower oil and 1.6% salmon oil (Fsal rats) or 3.4% sunflower oil and 1.6% safflower oil (Fsaf rats) (8–10). The major aim of the present study was to explore the possible correlation, at the individual level, between the percentage of glycated hemoglobin, considered as indicative of glucose homeostasis, and 55 other variables measured in plasma, liver, heart, kidney, soleus muscle or visceral adipose tissue. For each of these variables, individual data were collected from 20–23 animals.

Materials and methods

Biological variable analysis

The methods used to measure glycated hemoglobin (5), plasma albumin, urea, creatinine, calcium, iron, phospholipid, triglyceride and HDL-cholesterol (8), hepatic glucokinase activity and liver cholesterol, triglyceride and phospholipid content (8), systolic arterial blood pressure (9), plasma leptin concentration (9), kidney proliferating cell nuclear antigen index (9), liver, heart, kidney, soleus muscle or visceral adipose tissue glutathione reductase, superoxide dismutase and catalase activity (9), plasma, liver heart, kidney, soleus muscle or visceral adipose tissue thiobarbituric acid reactive substances, carbonyl derivatives, hydroperoxides and nitric acid content (10) were previously described in the references cited. This study was approved by the ethics committee of the Université Libre de Bruxelles.

Correlation analysis

In the correlation data, the xy values refer to the product of the differences, at the individual level and for the two variables under consideration, between the recorded individual measurement and the corresponding mean value. The correlation analysis was performed by W.J. Malaisse, one of the authors of the present article, without the use of any software.

Results

Correlation between glycated hemoglobin and selected plasma variables

The percentage of glycated hemoglobin was considered to be indicative of glucose homeostasis. Table I presents the results of a correlation analysis between glycated hemoglobin and nine plasma variables. Significant positive correlations were found between glycated hemoglobin and plasma albumin, urea, creatinine, phospholipids, triglycerides and total cholesterol concentrations, whilst negative correlations were found between glycated hemoglobin and plasma calcium, iron and HDL-cholesterol concentrations. In several cases with positive correlations, no negative xy product (two cases), or only two negative xy products (two cases) were recorded among the 23 xy products.

Table I

Correlation between glycated hemoglobin percentage and selected plasma variables.

Table I

Correlation between glycated hemoglobin percentage and selected plasma variables.

VariableCorrelation
Albumin+0.9111 (P<0.001)
Urea+0.7378 (P<0.001)
Creatinine+0.8360 (P<0.001)
Calcium−0.4709 (P<0.03)
Iron−0.5008 (P<0.02)
Phospholipids+0.8680 (P<0.001)
Triglycerides+0.9125 (P<0.001)
Total cholesterol+0.7837 (P<0.001)
HDL-cholesterol−0.5431 (P<0.009)

[i] HDL, high density lipoprotein.

Correlation between glycated hemoglobin and selected liver variables

The results from the correlation analysis between glycated hemoglobin percentage and selected liver variables are presented in Table II. No significant correlation was observed between the percentage of glycated hemoglobin and hepatic glucokinase activity. However, a significant positive correlation was observed between glycated hemoglobin and liver cholesterol, triglyceride and phospholipid content, with either no negative xy product (two cases) or only one negative xy product (one case).

Table II

Correlation between glycated hemoglobin percentage and selected liver variables.

Table II

Correlation between glycated hemoglobin percentage and selected liver variables.

VariableCorrelation
Glucokinase activity−0.0781 (P>0.1)a
Cholesterol content+0.9310 (P<0.001)
Triglyceride content+0.9962 (P<0.001)
Phospholipid content+0.9818 (P<0.001)

a n=22; n=23 in all other cases.

Correlation between glycated hemoglobin and blood pressure, leptin and kidney proliferating cell nuclear antigen index

A significant positive correlation (r=+0.9127; n=23; P<0.001) was observed between the percentage of glycated hemoglobin and the incremental area under the curve associated with changes in systolic arterial blood pressure as a function of time over a period of 56 days. Similarly, a highly significant positive correlation was found between glycated hemoglobin and plasma leptin concentration (r=+0.9890; n=23; P<0.001), without a negative xy product. The correlation coefficient between glycated hemoglobin and the kidney proliferating cell nuclear antigen index was +0.5589 (n=23), yielding P<0.008.

Correlation between glycated hemoglobin and selected enzymatic activities

As shown in Table III, no significant correlation was identified between glycated hemoglobin percentage and the activity of glutathione reductase in the liver, heart, kidney, soleus muscle or visceral adipose tissue. With the exception of the adipose tissue, there was a trend towards a negative correlation. However, even when the enzymatic measurements obtained from the liver, heart and kidney were expressed relative to the mean corresponding value recorded in Ssun rats, the correlation coefficient between the normalized values and those concerning glycated hemoglobin were not statistically significant (r=−0.2148; n=69; P<0.08).

Table III

Correlation between glycated hemoglobin percentage and selected enzymatic activities.

Table III

Correlation between glycated hemoglobin percentage and selected enzymatic activities.

OrganGlutathione reductaseSuperoxide dismutaseCatalase
Liver−0.2094 (P>0.1)−0.8067 (P<0.001)−0.4869 (P<0.03)
Heart−0.1799 (P>0.1)−0.9169 (P<0.001)−0.4809 (P<0.03)
Kidney−0.3768 (P<0.08)−0.7388 (P<0.001)−0.4282 (P<0.05)
Soleus muscle−0.1428 (P>0.1)a−0.9115 (P<0.001)−0.4546 (P<0.04)
Adipose tissue+0.2449 (P>0.1)−0.9405 (P<0.001)−0.5616 (P<0.008)

a n=20; n=23 in all other cases.

By contrast, highly significant negative correlations (P<0.001) were identified in all five organs between the percentage of glycated hemoglobin and the activity of superoxide dismutase (Table III). Significant negative correlations (P<0.05 or less) were also observed in these five organs between the individual values for glycated hemoglobin percentage and catalase activity (Table III).

Correlation between glycated hemoglobin and selected metabolites

Positive correlations were observed between the content of thiobarbituric acid reactive substances (TBARS), carbonyl derivatives and hydroperoxides in the plasma, liver, heart, kidney, soleus muscle and visceral adipose tissue, on one hand, and glycated hemoglobin, on the other, such positive correlations only failing to achieve statistical significance in two out of eighteen comparisons (Table IV). Likewise, with the exception of the soleus muscle, highly significant negative correlations (P<0.001) were observed between glycated hemoglobin percentage and the nitric oxide (NO) content of plasma, liver, heart, kidney or visceral adipose tissue (Table IV).

Table IV

Correlation between glycated hemoglobin percentage and selected metabolites.

Table IV

Correlation between glycated hemoglobin percentage and selected metabolites.

OrganTBARSCarbonylsHydroperoxidesNO
Plasma+0.9451 (P<0.001)+0.6655 (P<0.001)+0.8774 (P<0.001)−0.9047 (P<0.001)
Liver+0.7318 (P<0.001)+0.7765 (P<0.001)+0.6555 (P<0.001)−0.6648 (P<0.001)
Heart+0.6550 (P<0.001)+0.6259 (P<0.003)+0.7042 (P<0.001)a−0.7585 (P<0.001)
Kidney+0.7136 (P<0.001)+0.3828 (P<0.08)+0.4899 (P<0.03)−0.8589 (P<0.001)
Soleus muscle+0.7619 (P<0.001)+0.5864 (P<0.006)+0.8287 (P<0.001)+0.4761 (P<0.03)
Adipose tissue+0.8343 (P<0.001)+0.4820 (P<0.03)+0.3220 (P>0.1)−0.8369 (P<0.001)

a n=21; n=23 in all other cases.

{ label (or @symbol) needed for fn[@id='tfn5-etm-08-04-1275'] } TBARS, thiobarbituric acid reactive substances; NO, nitric oxide.

Discussion

Only two variables failed to display a significant correlation with the percentage of glycated hemoglobin. One of these was liver glucokinase activity. The only difference between the four groups of rats with regard to liver glucokinase activity was that higher activity was observed in the Fsal rats compared with the Ssun, Fsun or Fsaf rats (8). Therefore, it is hypothesized that this difference may be attributed to the greater supply of long-chain ω3 fatty acids in the diet of the Fsal rats compared with that in the diets of the other three groups of rats (8). In addition, no significant correlations were observed between glycated hemoglobin percentage and the enzyme activity of glutathione reductase in the liver, heart, kidney, soleus muscle and visceral adipose tissue. In these organs, the trend was towards a negative correlation.

A positive correlation with glycated hemoglobin percentage was observed for the plasma albumin concentration. Since an opposite situation could speculatively be expected from either liver dysfunction or renal albuminuria in the rats with severe metabolic syndrome, this positive correlation may reflect a modest degree of hemoconcentration in these rats. The positive correlations observed for glycated hemoglobin percentage with plasma urea and creatinine may reflect incipient nephropathy (8).

In terms of the cause-and-effect relationship, the negative correlations observed for glycated hemoglobin percentage with plasma calcium or iron concentrations remain unclear. They may, as discussed previously (8), be attributed to impaired gastrointestinal absorption of these metals.

The correlation between the percentage of glycated hemoglobin and the plasma concentration or liver content of cholesterol, triglycerides and phospholipids invariably yielded significant positive correlations, whereas a negative correlation was observed in the case of plasma HDL-cholesterol. These results demonstrate the tight correlation between perturbations of glucose homeostasis and the plasma concentrations or liver content of distinct types of lipids.

Furthermore, although glutathione reductase activity had no correlation with glycated hemoglobin concentration, the activity of superoxide dismutase or catalase in liver, heart, kidney, soleus muscle and visceral adipose tissue, as well as the plasma concentration or tissue content of TBARS, carbonyl derivatives and hydroperoxides were all correlated with the measurements of glycated hemoglobin, with only one clear exception (P>0.1) out of 28 comparisons. The negative correlations found for superoxide dismutase and catalase coincided with positive correlations in the case of variables indicative of oxidative stress, including the accumulation of TBARS, carbonyl derivatives and hydroperoxides.

Furthermore, the NO content of plasma, liver, heart, kidney or adipose tissue, but not that of soleus muscle, was negatively correlated with the glycated hemoglobin percentage.

In conclusion, without prejudging the cause-and-effect link between distinct variables, the present study documents the tight coordination in the metabolic, enzymatic and functional response to changes in the dietary supply of long-chain polyunsaturated ω3 and ω6 fatty acids to rats displaying a fructose-induced metabolic syndrome. All the correlations between the 55 variables under consideration were calculated by reference to the measurements of glycated hemoglobin. Hence, the latter measurements appear as most appropriate to judge the severity of biochemical and biophysical alterations in this animal model of the metabolic syndrome.

References

1 

Boukortt FO, Madani Z, Mellouk Z, Louchami K, Sener A and Ait Yahia D: Nutritional factors and fructose-induced metabolic syndrome. Metab Funct Res Diab. 4:18–34. 2011.

2 

Cancelas J, Prieto PG, Villanueva-Peñacarrillo ML, Zhang Y, Portois L, Sener A, Carpentier YA, Valverde I and Malaisse WJ: Glucose intolerance associated to insulin resistance and increased insulin secretion in rats depleted in long-chain polyunsaturated ω3 fatty acids. Horm Metab Res. 39:823–825. 2007.PubMed/NCBI

3 

Prieto PG, Cancelas J, Moreno P, Villanueva-Peñacarrillo ML, Malaisse WJ and Valverde I: Effect of diet supplementation with olive oil and guar upon fructose-induced insulin resistance in normal rats. Endocrine. 31:294–299. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Mellouk Z, Hachimi Idrissi T, Louchami K, Hupkens E, Malaisse WJ, Ait Yahia D and Sener A: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. I Intraperitoneal glucose tolerance test. Int J Mol Med. 28:1087–1092. 2011.

5 

Mellouk Z, Hachimi Idrissi T, Louchami K, Hupkens E, Sener A, Ait Yahia D and Malaisse WJ: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. II Time course of changes in food intake, body weight, plasma glucose and insulin concentrations and insulin resistance. Int J Mol Med. 29:113–118. 2012.

6 

Mellouk Z, Zhang Y, Bulur N, Louchami K, Malaisse WJ, Ait Yahia D and Sener A: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. III Secretory behaviour of isolated pancreatic islets. Int J Mol Med. 29:285–290. 2012.

7 

Mellouk Z, Zhang Y, Bulur N, Louchami K, Malaisse WJ, Ait Yahia D and Sener A: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. III Secretory behaviour of isolated pancreatic islets. Int J Mol Med. 29:285–290. 2012.

8 

Mellouk Z, Louchami K, Hupkens E, Sener A, Ait Yahia D and Malaisse WJ: The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated ω3 and ω6 fatty acids. V Post-mortem findings. Mol Med Reports. 6:1399–1403. 2012.

9 

Mellouk Z, Hupkens E, Antoine M-H, Sener A, Ait Yahia D and Malaisse WJ: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. VI Further post-mortem investigations. Mol Med Reports. 6:1404–1408. 2012.

10 

Mellouk Z, Sener A, Ait Yahia D and Malaisse WJ: The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated ω3 and ω6 fatty acids. VII Oxidative stress. Mol Med Reports. 6:1409–1412. 2012.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mellouk Z, Sener A, Ait Yahia D and Malaisse WJ: Interdependency of selected metabolic variables in an animal model of metabolic syndrome. Exp Ther Med 8: 1275-1278, 2014.
APA
Mellouk, Z., Sener, A., Ait Yahia, D., & Malaisse, W.J. (2014). Interdependency of selected metabolic variables in an animal model of metabolic syndrome. Experimental and Therapeutic Medicine, 8, 1275-1278. https://doi.org/10.3892/etm.2014.1886
MLA
Mellouk, Z., Sener, A., Ait Yahia, D., Malaisse, W. J."Interdependency of selected metabolic variables in an animal model of metabolic syndrome". Experimental and Therapeutic Medicine 8.4 (2014): 1275-1278.
Chicago
Mellouk, Z., Sener, A., Ait Yahia, D., Malaisse, W. J."Interdependency of selected metabolic variables in an animal model of metabolic syndrome". Experimental and Therapeutic Medicine 8, no. 4 (2014): 1275-1278. https://doi.org/10.3892/etm.2014.1886
Copy and paste a formatted citation
x
Spandidos Publications style
Mellouk Z, Sener A, Ait Yahia D and Malaisse WJ: Interdependency of selected metabolic variables in an animal model of metabolic syndrome. Exp Ther Med 8: 1275-1278, 2014.
APA
Mellouk, Z., Sener, A., Ait Yahia, D., & Malaisse, W.J. (2014). Interdependency of selected metabolic variables in an animal model of metabolic syndrome. Experimental and Therapeutic Medicine, 8, 1275-1278. https://doi.org/10.3892/etm.2014.1886
MLA
Mellouk, Z., Sener, A., Ait Yahia, D., Malaisse, W. J."Interdependency of selected metabolic variables in an animal model of metabolic syndrome". Experimental and Therapeutic Medicine 8.4 (2014): 1275-1278.
Chicago
Mellouk, Z., Sener, A., Ait Yahia, D., Malaisse, W. J."Interdependency of selected metabolic variables in an animal model of metabolic syndrome". Experimental and Therapeutic Medicine 8, no. 4 (2014): 1275-1278. https://doi.org/10.3892/etm.2014.1886
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team